This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Together, the organizations will seek to harness the power of generative AI to help pharmaceutical and lifescience manufacturers drive efficiencies and business value while improving patient outcomes.
This capability is attracting pharmaceutical and lifescience companies, health care providers and research organizations to take a closer look at Seqster’s offering. Takeda is one of the organizations that has implemented Seqster’s solution, leveraging real-time data for research and patient services.
Basel, Switzerland 28, January 2025 Lyfegen , a global innovator in drug market access, pricing, and rebate management, has announced a transformative collaboration with EVERSANA , a leading provider of global commercial services to the lifesciences industry, to revolutionize drug pricing and access through artificial intelligence-driven insights.
When announced, the news was a signal that health care and the larger tech-enabled ecosystem that supports health and well-being is embedded in peoples’ everyday lives. We can expect to see more women-related health tech featured at CES 2022, including on education panels and speaking platforms.
The funding will support Briya’s mission to transform how data is exchanged between healthcare organizations and lifesciences organizations, with particular emphasis on supporting the United States health ecosystem. The company’s scalable data exchange platform enables hospitals to capitalize on their patient data. .”
About EVERSANA EVERSANA is a leading independent provider of global services to the lifesciences industry. The companys integrated solutions are rooted in the patient experience and span all stages of the product life cycle to deliver long-term, sustainable value for patients, prescribers, channel partners and payers.
There’s a gap between the supply of digitalhealth tools that hospitals and health systems offer patients, and what patients-as-consumers need for overall health and wellbeing. Nowhere in the top 10 most commonly provided digital tools is one for price transparency, cost comparing or cost estimating. .
Our mission is to accelerate the commercialization of breakthrough innovations like the AUTAC platform for health impact, and we welcome Automera and ALSP to Singapore’s growing lifesciences translational community.” Together, we advance Singapore as a global lifesciences translational hub.
The lifesciences industry continues to innovate, providing diagnostics, therapeutics, and treatments to support the population through the COVID-19 pandemic. Lifesciences companies are also high-impact job creators, with surveyed companies forecasting nearly 6,000 employees in 2023 — up 1,800 (44.3%) from 2022.
Trust has become a key currency in provider/patient/supplier relationships: 94% of health executives say treating customers as partners is important to gain trust, according to the DigitalHealth Tech Vision 2018 from Accenture. Accenture’s vision this year is built on five pillars: Citizen AI. Extended Reality. Data Veracity.
BOSTON–( BUSINESS WIRE )– Labviva , the AI-driven lifesciencesdigital marketplace that simplifies and scales purchasing processes, announced today that it has secured $20 million in Series A financing led by Biospring Partners, with participation from existing investors Senator Investment Group, B Capital Group, and Glasswing Ventures.
The Report shows that the world’s leading pharmaceutical companies continue to spurn the opportunity to connect via social media at a local level. Roche Pharmaceuticals 3. Bayer (Pharmaceuticals Division) 4. Pfizer, Janssen, Novartis, Novo Nordisk, AbbVie and Takeda Pharmaceutical have at least 11 local apps available.
The acquisition immediately expands EVERSANA’s European operations and worldwide capabilities to help pharmaceutical, medical device, and emerging biotech companies globally launch products, expand market access, or solve unique geographic and market-specific challenges. .
In thinking holistically about effective management of chronic conditions through self-care of patients partnering with providers, health plans, and other organizations, we can imagine the ecosystem even more broadly through: Nutrition and food with grocery stores and pharmacies.
A “one layered delivery network through which patients can move seamlessly as they age and their needs evolve” will be the new health care platform to meet patients’ demands by 2030, according to a forecast from KPMG’s Healthcare and LifeSciences Institute. delivery and financing system.
The following is a guest article by Abhishek Khandelwal, Vice President, LifeSciences at Capgemini Engineering The convergence of digital technology and healthcare has been underway for quite some time, but as we inch closer to 2024, the pace of change that this sector is experiencing is unprecedented.
The newly appointed board members are: Jennifer Chavez, Senior Director, BioMed Realty Provides comprehensive commercial real estate transaction expertise and specialized business management services for BioMed Realtys Colorado portfolio, including the 23-building Flatiron Park, a hub for lifescience, quantum and technology innovation.
Studies The latest survey from Quantum Health and MedCity News found 84% of benefits consultants report that digitalhealth point solution fatigue continues among their clients. Feel Therapeutics launched Feel Monitor , a wearable for mental health monitoring.
EVERSANA INTOUCH Healthware joins five full-service affiliates and four specialty affiliates serving clients across the globe with world-class strategy, next-generation branding and creative, and innovative solutions to propel the future of lifescience marketing. They are, however, fully owned and operated by EVERSANA.
Purchase Expands Linus Health’s Cognitive Assessment Capabilities Linus Health , a digitalhealth company enabling early detection of Alzheimer’s and other dementias, today announced it has acquired Aural Analytics , a leader in clinical-grade speech analytics.
With the proven success to save on average 48% production time from traditional agency models, TEDAVI meets the dynamic needs of the pharmaceutical and lifescience industries. CHICAGO – Aug. TEDAVI showcases next-generation innovation while reinforcing a commitment to “pharmatize AI.”
BERLIN – October 7, 2024 – EVERSANA , a leading provider of global commercial services to the lifesciences industry, today announced the continued growth of its European footprint with a new office in Berlin, Germany, Europe’s largest pharmaceutical market.
Via the PhilRx Patient Access Platform, patients can now access Teva Pharmaceuticals’ Digihaler® family of inhalers SAN FRANCISCO–(BUSINESS WIRE)– Phil Inc., The goal of Phil and Teva Pharmaceuticals’ partnership is to help enable patients to receive and refill their Digihaler medication quickly, easily and affordably.
Born from an investment play by Healthware Ventures and led by industry experts Gerry Chillè and PierPaolo Iagulli , Newel Health is an innovative company that aims to improve healthcare for patients and doctors through the creation of beautifully designed and clinically validated digital medicine and digital therapeutic (DTx) solutions.
At the end of this day, something Muna Bhanji, an advisor to biopharmaceutical developers who spent over 30 years of her career with Merck, noted: no advances toward value-based care will happen without a sense of partnership, requiring aligned incentives across the health/care ecosystem.
NEW YORK–(BUSINESS WIRE)– CI&T (NYSE:CINT), a leader in driving AI-powered digital transformation for global brands, will be showcasing its innovative solutions to advance the future of healthcare and lifesciences at the 2024 HIMSS Global Health Conference taking place in Orlando, FL on March 11-15, 2024.
Chris McSpiritt, Head of LifeSciences at Domino Data Lab Next year will see AI-enhanced imaging technologies significantly improve diagnostic accuracy in radiology and pathology, empowering clinicians to make quicker and more reliable decisions at the point of care.
Financing will support the growth of an integrated specialty pharmaceutical company CAMBRIDGE, Mass.–(BUSINESS This matches very well with our focus and expertise as a Growth fund to support the scale-up of emerging champions of the European Healthcare and LifeScience ecosystem.” By Hodson L et al. J Med Toxicol.
Kelly Nguyen is a multi-award-winning, seasoned executive with a proven track record in the pharmaceutical and healthcare industry. Dr. Kelly Nguyen is an experienced entrepreneur and executive with a proven track record in the pharmaceutical and healthcare industry. About Diversity Alliance for Science (DA4S).
Klick Chief Medical Officer Holly Henry said Cappellino has the scientific background, clinical comprehension, and market access expertise they were looking for in a leader who can both develop the value story and generate maximum value for clients using health economics and outcomes research and real-world data.
This comes after Francisco Partners, a private equity firm, acquired the health analytics assets of IBM Watson Health in 2022 and rebranded the division as Merative. Merative's product portfolio will focus on six key areas: Health Insights: Providing actionable insights to improve healthcare delivery and decision-making.
Investment Marks a Significant Milestone in Advancing AI-Based Arrhythmia Care SAN DIEGO–(BUSINESS WIRE)– Vektor Medical , a pioneer in non-invasive, AI-based arrhythmia analysis technology, today announced a $16 million Series A investment co-led by Solas BioVentures and TVM Capital LifeScience. Solas puts patients first.
“Adding Blackford and its AI technology to our radiology portfolio secures Bayer an excellent position in the fastest growing segment within the overall global radiology industry,” said Stefan Oelrich, Member of the Board of Management, Bayer AG and President of Bayer’s Pharmaceutical Division.
The seed round was co-led by Wellington Partners and Forbion and includes non-dilutive financing from BMBF GO-Bio, a prestigious German government initiative aimed at supporting the most innovative startups in the lifesciences. Forbion invests in lifesciences companies that are active in the (bio) pharmaceutical space.
CRNSV”) was formed by former executives and directors of Nymox Pharmaceutical Corporation (“Nymox” or the “Company”), who were improperly removed from their positions, with a goal to recover shareholder value in Nymox. & LONDON–(BUSINESS WIRE)– The Committee to Restore Nymox Shareholder Value, Inc. Randall Lanham, Esq.
Having spent many years in lifesciences in both research and as an entrepreneur, Koen now knows that getting and staying healthy isn’t about just developing medicines and med-tech: optimally, health requires a tincture of delight, Koen advises in his breakthrough, innovative book, Your Guide to Delight. Dr. Koen Kas believes.
The Impulse makes its debut at Frontiers Health and aims to drive patient-centric innovation, with a strong focus on sustainability, digitalhealth, and collaborative solutions. We stand at a pivotal moment for the pharmaceutical industry.
That’s a new bar not just for retail and banking, but for health care and insurance as well. And this is not only for providers and plans, but for pharma and lifescience companies, as well.
We learned this lesson during the pandemic quite clearly — connectivity as a social determinant of health. In addition to my discussion with Molly, you should also listen to two insightful colleagues’ conversations in the series, with: Dr.
and Slovenia across business, operations, lifescience and data science functions, and expanding its advisory boards. where it is co-presenting a poster with OncXerna Therapeutics and Regeneron Pharmaceuticals. Genialis is growing its teams in both the U.S. Genialis is attending AACR 2023 from April 14-19 in Orlando, Fla.,
These are just a few of the rumored big healthtech M&A deals that could happen in 2023 or 2024: Amazon acquiring Teladoc Health. The combined company would be a major player in the digitalhealth space, with a reach of millions of patients. This deal would create the largest health insurance company in the world.
The key trends that are expected to shape the market in 2023 include: Increased focus on digitalhealth: Healthcare companies are increasingly looking to acquire digitalhealth businesses in order to improve their offerings and stay ahead of the competition. Engage with the HealthTech Community Thoughts, comments?
COPENHAGEN (July 25, 2023) – Dawn Health , a global leader in digitalhealth, today released a patient companion App called Ekiva-MS to support people living with multiple sclerosis (PlwMS). Contact, Media Relations globalpress@dawnhealth.com +45 53 65 31 64 Saskia Coakley-Black
AI-powered* platform takes eCOA off the critical path to study startup for lifesciences industry PALO ALTO, Calif.–(BUSINESS Top-10 global pharmaceutical companies are already benefiting from Medable’s novel technology, shaving weeks off build times. –(BUSINESS WIRE)– Medable Inc. ,
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content